➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Colorcon
McKinsey
Medtronic
Dow

Last Updated: January 26, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Favipiravir

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Favipiravir?

Favipiravir is an investigational drug.

There have been 53 clinical trials for Favipiravir. The most recent clinical trial was a Phase 3 trial, which was initiated on April 20th 2020.

The most common disease conditions in clinical trials are Coronavirus Infections, Infection, and Severe Acute Respiratory Syndrome. The leading clinical trial sponsors are Novagenix Bioanalytical Drug R&D Center, MDVI, LLC, and Farmagen Ar-Ge Biyot. Ltd. Sti.

There are fifteen US patents protecting this investigational drug and three hundred and three international patents.

Recent Clinical Trials for Favipiravir
TitleSponsorPhase
Investigation the Effect of Montelukast in COVID-19Medipol UniversityPhase 2
Investigation the Effect of Montelukast in COVID-19The Scientific and Technological Research Council of TurkeyPhase 2
Investigation the Effect of Montelukast in COVID-19Bahçeşehir UniversityPhase 2

See all Favipiravir clinical trials

Clinical Trial Summary for Favipiravir

Top disease conditions for Favipiravir
Top clinical trial sponsors for Favipiravir

See all Favipiravir clinical trials

US Patents for Favipiravir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Favipiravir   Start Trial Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same Toyama Chemical Co., Ltd. (Tokyo, JP)   Start Trial
Favipiravir   Start Trial Pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof Toyama Chemical Co., Ltd. (Tokyo, JP)   Start Trial
Favipiravir   Start Trial Compositions and kits for treating influenza Adamas Pharmaceuticals, Inc. (Emeryville, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Colorcon
McKinsey
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.